Renal Cell Carcinoma: Comparison of RENAL Nephrometry and PADUA Scores with Maximum Tumor Diameter for Prediction of Local Recurrence after Thermal Ablation.

Purpose To evaluate the performance of the radius, exophytic or endophytic, nearness to collecting system or sinus, anterior or posterior, and location relative to polar lines (RENAL) nephrometry and preoperative aspects and dimensions used for anatomic classification (PADUA) scoring systems and other tumor biometrics for prediction of local tumor recurrence in patients with renal cell carcinoma after thermal ablation. Materials and Methods This HIPAA-compliant study was performed with a waiver of informed consent after institutional review board approval was obtained. A retrospective evaluation of 207 consecutive patients (131 men, 76 women; mean age, 71.9 years ± 10.9) with 217 biopsy-proven renal cell carcinoma tumors treated with thermal ablation was conducted. Serial postablation computed tomography (CT) or magnetic resonance (MR) imaging was used to evaluate for local tumor recurrence. For each tumor, RENAL nephrometry and PADUA scores were calculated by using imaging-derived tumor morphologic data. Several additional tumor biometrics and combinations thereof were also measured, including maximum tumor diameter. The Harrell C index and hazard regression techniques were used to quantify associations with local tumor recurrence. Results The RENAL (hazard ratio, 1.43; P = .003) and PADUA (hazard ratio, 1.80; P < .0001) scores were found to be significantly associated with recurrence when regression techniques were used but demonstrated only poor to fair discrimination according to Harrell C index results (C, 0.68 and 0.75, respectively). Maximum tumor diameter showed the highest discriminatory strength of any individual variable evaluated (C, 0.81) and was also significantly predictive when regression techniques were used (hazard ratio, 2.98; P < .0001). For every 1-cm increase in diameter, the estimated rate of recurrence risk increased by 198%. Conclusion Maximum tumor diameter demonstrates superior performance relative to existing tumor scoring systems and other evaluated biometrics for prediction of local tumor recurrence after renal cell carcinoma ablation. © RSNA, 2016.

[1]  R. Thompson,et al.  Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors. , 2013, The Journal of urology.

[2]  Walter Artibani,et al.  Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. , 2009, European urology.

[3]  I. Derweesh,et al.  RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis. , 2013, Urology.

[4]  Robert G Uzzo,et al.  The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. , 2009, The Journal of urology.

[5]  B. Matlaga,et al.  Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. , 2004, AJR. American journal of roentgenology.

[6]  J. Cadeddu,et al.  The performance of a modified RENAL nephrometry score in predicting renal mass radiofrequency ablation success. , 2015, Urology.

[7]  Alexander J. King,et al.  Percutaneous image-guided cryoablation of small renal masses , 2016, Abdominal Radiology.

[8]  R. Uzzo,et al.  Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. , 2011, European urology.

[9]  D. Gervais,et al.  Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. , 2005, AJR. American journal of roentgenology.

[10]  LianHuibo,et al.  The application of R.E.N.A.L. nephrometry scoring system in predicting the complications after laparoscopic renal radiofrequency ablation. , 2014 .

[11]  S. Stavropoulos,et al.  Contemporary Status of Percutaneous Ablation for the Small Renal Mass , 2016, Current Urology Reports.

[12]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Radiology.

[13]  John Trachtenberg,et al.  The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. , 2002, The Journal of urology.

[14]  I. Derweesh,et al.  Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score. , 2015, Urology.

[15]  A. Pantuck,et al.  Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas. , 2014, Journal of vascular and interventional radiology : JVIR.

[16]  Oguz Akin,et al.  Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems , 2015, World Journal of Urology.

[17]  R. Uzzo,et al.  Thermal ablation of the small renal mass: case selection using the R.E.N.A.L.-Nephrometry Score. , 2013, Urologic oncology.

[18]  A. Mottrie,et al.  Predictors of warm ischemia time and perioperative complications in a multicenter, international series of robot-assisted partial nephrectomy. , 2012, European urology.

[19]  S. Horenblas,et al.  Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy. , 2011, The Journal of urology.

[20]  J. Cronan,et al.  Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. , 2003, AJR. American journal of roentgenology.

[21]  J. Kaouk,et al.  Nephrometry score is associated with volume loss and functional recovery after partial nephrectomy. , 2012, The Journal of urology.

[22]  V. Master,et al.  R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience. , 2015, Journal of vascular and interventional radiology : JVIR.

[23]  M. Beland,et al.  Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients , 2016, European Radiology.

[24]  P. Liang,et al.  Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma , 2015, Abdominal Imaging.

[25]  Shouzhen Chen,et al.  Outcome of radiofrequency ablation over partial nephrectomy for small renal mass (<4 cm): a systematic review and meta-analysis. , 2015, International journal of clinical and experimental medicine.

[26]  E. Wallen,et al.  Preoperatively misclassified, surgically removed benign renal masses: a systematic review of surgical series and United States population level burden estimate. , 2015, The Journal of urology.

[27]  S. Nakada,et al.  Current practice patterns in the use of ablation technology for the management of small renal masses at academic centers in the United States. , 2008, Urology.

[28]  I. Summerhayes,et al.  Incomplete renal tumor destruction using radio frequency interstitial ablation. , 2002, The Journal of urology.

[29]  A. Briganti,et al.  Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study. , 2016, Urology.